ERBB2 and breast cancer: The decrease in HER2 positivity rate can also potentially be explained by the introduction of mammography screening with improved detection of early breast cancers, as screen detection resulted in a shift to a different patient population with less HER2 positive cases in early breast cancer and with younger age at diagnosis [39, 40].